Browsing by Author Wong, WLD

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 8 to 21 of 21 < previous 
TitleAuthor(s)Issue Date
 
Human Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Prevent Adriamycin Nephropathy in Mice
Journal:Oncotarget
Wu, HYiu, WHWong, WLDLi, RXChan, YYLeung, JCKZhang, YLian, QLai, KNTang, SCWTse, HF
2017
 
Inhibition of miR-34a reduces podocyte apoptosis by targeting Bcl-2 and autophagy
Proceeding/Conference:Journal of the American Society of Nephrology
Liu, YLi, RYiu, WHWu, HWong, WLDLeung, JCKChan, LYLai, KNSaleem, MMathieson, PWTang, SCW
2015
 
Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-Induced oxidative stress
Proceeding/Conference:Journal of the American Society of Nephrology
Yiu, WHWong, WLDWu, HLi, RChan, LYYLeung, JCKLan, HYLai, KNTang, SCW
2015
 
Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stress
Journal:Kidney International
Yiu, WHWong, WLDWu, HLi, RYam, IYLChan, YYLeung, JCKLan, HYLai, KNTang, SCW
2016
 
N-Acetyl-seryl-aspartyl-lysyl-proline Alleviates Renal Fibrosis Induced by Unilateral Ureteric Obstruction in BALB/C Mice
Journal:Mediators of Inflammation
Chan, GCWYiu, WHWu, HWong, WLDLin, MHuang, XRLan, HYTang, SCW
2015
 
Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy – Interim analysis of an add-on, randomised, controlled, multi-centre, open-label pragmatic trial
Proceeding/Conference:International Congress of Chinese nephrologists
Chan, KWKwong, ASKLui, SLIp, TPChan, GCWCowling, BJYiu, WHWong, WLDLI, BLI, YFeng, YTan, KCBChan, YYLeung, JCKLai, KNTang, SCW
2017
 
Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy – Preliminary results of an add-on, randomised, controlled, multi-centre, open-label pragmatic trial
Proceeding/Conference:Journal of the American Society of Nephrology
Chan, KWKwong, ASKLui, SLIp, TPChan, GCWCowling, BJYiu, WHWong, WLDLi, BLi, YFeng, YTan, KCBChan, YYLeung, JCKLai, KNTang, SCW
2017
 
Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy: Interim analysis of an add-on, randomised, controlled, multi-centre, open-label pragmatic trial
Proceeding/Conference:Hong Kong Medical Journal
Chan, KWKwong, ASKLui, SLIp, TPChan, GCWCowling, BJYiu, WHWong, WLDLi, BLi, YFeng, YTan, KCBChan, YYLeung, JCKLai, KNTang, SCW
2018
 
Semi-individualised Chinese Medicine Treatment for Diabetic Kidney Disease – From users’ perspectives to SCHEMATIC trial interim result and potential mechanisms
Proceeding/Conference:Advances in Integrative Medicine
Chan, KWKwong, ASKChan, GCWLeung, CPSYiu, WHLui, SLIp, TPCowling, BJWong, WLDLi, BLi, YFeng, YChan, YYLeung, JCKTan, KCBWong, CWVLai, KNTang, SCW
2019
 
Spleen Tyrosine Kinase Inhibitor Ameliorates Tubular Inflammation in IgA Nephropathy.
Proceeding/Conference:Journal of the American Society of Nephrology
Yiu, WHWong, WLDWu, HChan, KWLiu, YChan, LYYLeung, JCKLai, KNTang, SCW
2016
 
The Expectation, Concern, and Experience of patients towards Integrative Chinese-western Medicine for Diabetic Kidney Disease: A qualitative study
Proceeding/Conference:Journal of the American Society of Nephrology
Chan, KWLeung, CChan, GCWYiu, WHWong, WLDLi, BLi, YChan, YYLeung, JCKTang, SCW
2017
 
Thrombin induces Epithelial-Mesenchymal Transition through the activation of PAR-1 in Tubular Epithelial Cells
Proceeding/Conference:Journal of the American Society of Nephrology
Yiu, WHWong, WLDLeung, JCKChan, LYYLai, KNTang, SCW
2014
 
Tissue kallikrein mediates pro-inflammatory pathways and activation of protease-activated receptor-4 in proximal tubular epithelial cells.
Journal:PLoS ONE
Yiu, WHWONG, WLDChan, YYLeung, JCKChan, KWlan, HYLai, KNTang, SCW
2014
 
The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy
Journal:Kidney International
Lin, MIAOYiu, WHLI, RWU, HWONG, WLDChan, YYLeung, JCKLai, KNTang, SCW
2013
Showing results 8 to 21 of 21 < previous